LA JOLLA, Calif.--(BUSINESS WIRE)--Burnham Institute for Medical Research (Burnham) has appointed Michael R. Jackson, Ph.D., to the newly created position of Vice President for Drug Discovery and Development. In this role, Dr. Jackson will oversee the chemical biology and drug discovery efforts of the Conrad Prebys Center for Chemical Genomics (CPCCG) at Burnham’s La Jolla, California and Orlando, Florida campuses. He will lead Burnham’s efforts to identify drug candidates, developing promising chemical compounds into new medicines and creating partnerships for preclinical and clinical drug development.
